Screening for human papillomavirus, cervical cytological abnormalities and associated risk factors in HIV-positive and HIV-negative women in Rwanda.
M F MukanyangeziV SengpielO ManziG TobinS RulisaE BienvenuDaniel GiglioPublished in: HIV medicine (2017)
The currently used quadrivalent vaccine may be insufficient to give satisfactory HPV coverage in Rwanda. HPV Screening may be effective to identify women at risk of developing cervical cancer, particularly if provided to high-risk patients.
Keyphrases
- hiv positive
- antiretroviral therapy
- men who have sex with men
- cervical cancer screening
- south africa
- end stage renal disease
- polycystic ovary syndrome
- hiv infected
- human immunodeficiency virus
- hiv testing
- high grade
- newly diagnosed
- chronic kidney disease
- hiv aids
- hepatitis c virus
- prognostic factors
- peritoneal dialysis
- metabolic syndrome
- breast cancer risk
- patient reported